Online: 23 August 2021 (10:38:52 CEST)
Show abstract| Download PDF| Share
Online: 24 October 2024 (10:27:54 CEST)
Show abstract| Download PDF| Share
Online: 31 January 2024 (05:46:56 CET)
Online: 25 January 2024 (08:15:20 CET)
Show abstract| Download PDF| Share
Online: 3 January 2024 (08:36:12 CET)
Show abstract| Download PDF| Share
Online: 9 February 2021 (09:48:42 CET)
Show abstract| Download PDF| Share
Online: 31 October 2024 (07:07:25 CET)
Show abstract| Download PDF| Share
Online: 9 October 2024 (08:38:32 CEST)
Show abstract| Download PDF| Share
Online: 15 July 2024 (19:40:21 CEST)
Show abstract| Download PDF| Share
Subject: Chemistry And Materials Science, Biomaterials Keywords: There are many molecules used as drug carrier. TUD-1 is a newly synthesized mesoporous silica (SM) molecule possess two important features; consists of mesoporous so it is very suitable to be drug carrier in addition to that it has the ability to induce apoptosis in cancer cells. However, the effect of TUD-1 appears to act as cell death inducer, regardless of whether it is necrosis or apoptosis. Unfortunately, recent studies indicate that a proportion of cells undergo necrosis rather than apoptosis, which limits the use of TUD-1 as a secure treatment. On the other hand, lithium considered as necrosis inhibitor element. Hence, current study based on the idea of production a new Li/TUD-1 by incorporated mesoporous silica (TUD-1 type) with lithium in order to produce a new compound that has the ability to activate apoptosis by mesoporous silica (TUD-1 type) and at the same time can inhibit the activity of necrosis by lithium. Herein, lithium was incorporated in TUD-1 mesoporous silica by
Online: 4 October 2018 (15:54:02 CEST)
Show abstract| Download PDF| Share
  • Page
  • of
  • 16
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.